Hsa-miR-105-5p acts as an oncogene in triple-negative breast cancer.
10.1097/CM9.0000000000002689
- Author:
Da QIAN
1
;
Tao ZHOU
2
;
Hanchu XIONG
3
;
Yuhao XU
4
;
Jie QIU
4
;
Yihao WU
5
;
Weimin HONG
2
;
Xuli MENG
6
Author Information
1. Department of Burn and Plastic Surgery-Hand Surgery, The Changshu Hospital Affiliated to Soochow University, Changshu, Jiangsu 215000, China.
2. Faculty of Basic Medicine, Hangzhou Medical College, Hangzhou, Zhejiang 310014, China.
3. Cancer Center, Department of Radiation Oncology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang 314408, China.
4. Second Clinical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310014, China.
5. College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou, Zhejiang 310014, China.
6. Cancer Center, Department of Breast Surgery, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, Zhejiang 314408, China.
- Publication Type:Journal Article
- MeSH:
Humans;
Triple Negative Breast Neoplasms/genetics*;
MicroRNAs/genetics*;
Oncogenes;
Cell Line, Tumor;
Cell Proliferation;
Gene Expression Regulation, Neoplastic;
Cell Movement
- From:
Chinese Medical Journal
2023;136(24):3022-3024
- CountryChina
- Language:English
